Concepedia

Paul A. VanderLaan

PA

Statistics

Publications

76

Citations

4.9K

H-Index

34

Active since

2007

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Brigham and Women's Hospital

Medical University of Vienna

Massachusetts General Hospital

Paul A. VanderLaan is an author at Beth Israel Deaconess Medical Center specializing in medicine, oncology, and lung cancer.

Publications per year

2007–2024

76

Publications

76

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Matthew J. Niederst, Lecia V. Sequist, John T. Poirier et al. · Nature Communications · 2015 · 633 citations · Full text

Medicine, Cancer Biology, Oncology +17

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

Deepa Rangachari, Norihiro Yamaguchi, Paul A. VanderLaan et al. · Lung Cancer · 2015 · 526 citations · Full text

Medicine, Cancer Biology, Oncology +14

The 2023 Bethesda System for Reporting Thyroid Cytopathology

Syed Z. Ali, Zubair Baloch, Béatrix Cochand‐Priollet et al. · Thyroid · 2023 · 330 citations

Medicine, Pathology, Cytopathology +12

Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations

Paul A. VanderLaan, Ellen Marqusee, Jeffrey F. Krane · American Journal of Clinical Pathology · 2011 · 219 citations · Full text

Medicine, Pathology, Surgery +17

Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes

Paul A. VanderLaan, Deepa Rangachari, Susan M. Mockus et al. · Lung Cancer · 2017 · 208 citations · Full text

Medicine, Genetics, Oncology +16

1–5 of 76